Brief: China NT Pharma Group Company Posts FY Loss Attributable Of RMB 587.6 Mln
15/04/2020 16:09
April 15 (Reuters) - China NT Pharma Group Company Ltd
1011.HK :
* FY LOSS ATTRIBUTABLE RMB587.6 MILLION VERSUS LOSS OF
RMB957.7
MILLION
* FY REVENUE FROM CONTS OPERATIONS RMB366 MILLION VERSUS
RMB571.5
MILLION
Source text for Eikon: urn:newsml:reuters.com:*:nHKS8Syv3m
Further company coverage: 1011.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China NT Pharma Co
See all newsBrief: China NT Pharma Group Says Expected Loss For Year Further Reduced By HK$15.4 Million As Compared With Prior Guidance
Brief: China Nt Pharma Expects Net Loss Attributable Of RMB25 MLN To RMB30 MLN In FY
Brief: China NT Pharma Makes Application For Resumption Of Trading On Feb 11
Brief: HKEX Says Trading In Shares Of China NT Pharma Group Company Halted
Brief: China Nt Pharma Group Says To Issue Bonds In Aggregate Principal Amount Of HK$65 Million